Regeneron Pharmaceuticals Inc (REGN)
744.42
+1.07
(+0.14%)
USD |
NASDAQ |
Nov 21, 16:00
746.00
+1.58
(+0.21%)
After-Hours: 20:00
Regeneron Pharmaceuticals Profit Margin (Quarterly): 36.03% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 36.03% |
| June 30, 2024 | 40.38% |
| March 31, 2024 | 22.96% |
| December 31, 2023 | 33.77% |
| September 30, 2023 | 29.97% |
| June 30, 2023 | 30.66% |
| March 31, 2023 | 25.86% |
| December 31, 2022 | 35.06% |
| September 30, 2022 | 44.81% |
| June 30, 2022 | 29.82% |
| March 31, 2022 | 32.83% |
| December 31, 2021 | 45.01% |
| September 30, 2021 | 47.27% |
| June 30, 2021 | 60.31% |
| March 31, 2021 | 44.10% |
| December 31, 2020 | 47.43% |
| September 30, 2020 | 36.71% |
| June 30, 2020 | 45.97% |
| March 31, 2020 | 34.16% |
| December 31, 2019 | 42.50% |
| September 30, 2019 | 38.40% |
| June 30, 2019 | 12.24% |
| March 31, 2019 | 33.59% |
| December 31, 2018 | |
| September 30, 2018 | 35.75% |
| Date | Value |
|---|---|
| June 30, 2018 | 34.29% |
| March 31, 2018 | 31.62% |
| December 31, 2017 | 10.96% |
| September 30, 2017 | 25.88% |
| June 30, 2017 | 26.38% |
| March 31, 2017 | 18.87% |
| December 31, 2016 | 20.63% |
| September 30, 2016 | 21.70% |
| June 30, 2016 | 16.18% |
| March 31, 2016 | 15.10% |
| December 31, 2015 | 14.12% |
| September 30, 2015 | 18.50% |
| June 30, 2015 | 19.49% |
| March 31, 2015 | 8.74% |
| December 31, 2014 | 11.23% |
| September 30, 2014 | 11.49% |
| June 30, 2014 | 14.47% |
| March 31, 2014 | 10.92% |
| December 31, 2013 | 14.12% |
| September 30, 2013 | 23.67% |
| June 30, 2013 | 19.09% |
| March 31, 2013 | 22.49% |
| December 31, 2012 | |
| September 30, 2012 | 44.77% |
| June 30, 2012 | 25.21% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
22.96%
Minimum
Mar 2024
60.31%
Maximum
Jun 2021
38.28%
Average
36.37%
Median
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 33.28% |
| Eli Lilly and Co | 8.48% |
| Pfizer Inc | 25.22% |
| Biogen Inc | 15.76% |
| AbbVie Inc | 10.80% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.19% |
| Return on Assets | 13.44% |
| Return on Invested Capital | 16.02% |
| Gross Profit Margin (Quarterly) | 86.80% |
| Operating Margin (Quarterly) | 33.21% |
| Return on Net Operating Assets | 33.97% |